Gibson, Dunn & Crutcher represented Apogee Therapeutics, Inc. in the offering, and Cooley represented the underwriters.Apogee Therapeutics, Inc. (Nasdaq: APGE), a clinical-stage biotechnology company, announced the closing…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
